Dapagliflozin for Anemia in Lower-Risk Myelodysplastic Syndromes

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Dapagliflozin for Anemia in Lower-Risk Myelodysplastic Syndromes	Hemic and Lymphatic Diseases, anemia, bone marrow disorder, hematologic disorder, myelodysplastic syndrome	Not yet recruiting	Phase 2	2026-04-08		NCT07516847

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Boryung Pharmaceutical Co., Ltd	32
Seug yun Yoon, MD	1

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials